CIBERER, Centro de Investigación Biomédica en Red de Enfermedades Raras, is a renowned brand dedicated to advancing research on rare diseases. With a mission to improve the understanding, diagnosis, and treatment of these conditions, CIBERER brings together various institutions and experts in the field. Their research is conducted by specialized clinical and investigative groups that cover a wide range of disciplines, including genomic medicine, mitochondrial and metabolic medicine, neurological disorders, pediatric medicine, and endocrine medicine.

CIBERER also supports projects funded through competitive calls, focusing on cross-cutting programs and the development of human resources, knowledge application, internationalization, and scientific dissemination. As part of their commitment to rare disease research, CIBERER provides access to important platforms such as the Biobank, ORPHANET, BIER, and the Spanish Variant Server. These resources play a vital role in facilitating the study and understanding of rare diseases.

CIBERER is at the forefront of precision medicine in Spain, with its IMPaCT infrastructure driving advancements in personalized healthcare. Their dedication to empowering patients and advancing scientific knowledge makes CIBERER a leading force in the field of rare disease research